16.46

5.27% 0.90

Neogenomics Inc (NEO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt NEO? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$15.56

Offen:

$15.86

24-Stunden-Volumen:

471.58K

Relative Volume:

0.18

Marktkapitalisierung:

$2.14B

Einnahmen:

$745.97M

Nettoeinkommen (Verlust:

$-99.21M

KGV:

-21.30

EPS:

-0.7729

Netto-Cashflow:

$-5.09M

1W Leistung:

+7.13%

1M Leistung:

+12.97%

6M Leistung:

+43.43%

1J Leistung:

+184.38%

1-Tages-Spanne:

$15.86

$16.45

1-Wochen-Bereich:

$15.34

$16.45

52-Wochen-Spanne:

$5.63

$16.45

Neogenomics Inc Stock (NEO) Company Profile

Firmenname

Neogenomics Inc

Sektor

Healthcare (1083)

Branche

Diagnostics & Research (49)

Telefon

(239) 768-0600

Adresse

9490 NEOGENOMICS WAY, FORT MYERS, FL

Mitarbeiter

2,500

Twitter

@NeoGenomics

Nächster Verdiensttermin

2026-07-28

Neueste SEC-Einreichungen

NEO's Discussions on Twitter

Compare NEO vs TMO, DHR, IDXX, NTRA, A

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NEO Neogenomics Inc	16.45	1.71B	745.97M	-99.21M	-5.09M	-0.7729
TMO Thermo Fisher Scientific Inc	587.66	207.93B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	204.08	138.14B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	589.39	43.87B	4.45B	1.10B	1.06B	13.59
NTRA Natera Inc	321.32	36.95B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	144.82	38.94B	7.23B	1.41B	1.09B	4.979

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-30	Herabstufung	BTIG Research	Buy → Neutral
2025-07-29	Herabstufung	William Blair	Outperform → Mkt Perform
2025-05-15	Eingeleitet	Guggenheim	Neutral
2025-04-30	Herabstufung	Leerink Partners	Outperform → Market Perform
2025-01-13	Herabstufung	The Benchmark Company	Buy → Hold
2024-12-10	Eingeleitet	Jefferies	Buy
2024-05-01	Fortgesetzt	Craig Hallum	Buy
2023-12-29	Bestätigt	BTIG Research	Buy
2023-08-21	Hochstufung	Stephens	Equal-Weight → Overweight
2023-05-16	Herabstufung	Raymond James	Outperform → Mkt Perform
2023-05-09	Hochstufung	BTIG Research	Neutral → Buy
2023-02-24	Hochstufung	The Benchmark Company	Hold → Buy
2023-02-01	Hochstufung	Needham	Hold → Buy
2022-08-26	Herabstufung	The Benchmark Company	Buy → Hold
2022-08-22	Herabstufung	Needham	Buy → Hold
2022-06-03	Eingeleitet	Piper Sandler	Overweight
2022-03-29	Herabstufung	BofA Securities	Buy → Neutral
2022-03-29	Herabstufung	Stephens	Overweight → Equal-Weight
2022-01-18	Fortgesetzt	Stephens	Overweight
2021-12-16	Eingeleitet	Cowen	Outperform
2021-11-05	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-10-14	Hochstufung	Raymond James	Mkt Perform → Outperform
2021-06-03	Eingeleitet	Goldman	Buy
2021-02-25	Fortgesetzt	Needham	Buy
2021-02-25	Herabstufung	Raymond James	Outperform → Mkt Perform
2021-01-28	Eingeleitet	Truist	Buy
2020-12-11	Fortgesetzt	BTIG Research	Buy
2020-10-28	Bestätigt	Needham	Buy
2020-09-09	Eingeleitet	Morgan Stanley	Overweight
2020-08-28	Eingeleitet	Guggenheim	Buy
2020-07-29	Bestätigt	Needham	Buy
2020-06-25	Eingeleitet	BofA/Merrill	Buy
2020-04-21	Fortgesetzt	Stephens	Overweight
2020-03-02	Fortgesetzt	Craig Hallum	Buy
2020-02-28	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2020-01-23	Herabstufung	First Analysis Sec	Strong Buy → Outperform
2019-10-30	Bestätigt	Needham	Buy
2019-05-01	Bestätigt	Needham	Buy
2019-03-29	Bestätigt	Needham	Buy
2019-01-03	Eingeleitet	Needham	Buy
2018-10-24	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2018-08-21	Eingeleitet	Leerink Partners	Outperform
2018-05-02	Herabstufung	First Analysis Sec	Overweight → Equal-Weight
2017-09-11	Herabstufung	BTIG Research	Buy → Neutral
2017-08-24	Eingeleitet	Gabelli & Co	Buy
2016-12-15	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Neogenomics Inc Aktie (NEO) Neueste Nachrichten

Jul 28, 2026

NeoGenomics (NEO) Is Down 7.7% After DOJ Settlement On Legacy Agreements – Has The Bull Case Changed? - simplywall.st

Jul 28, 2026

NeoGenomics in focus: Earnings test new diagnostic momentum By Investing.com - Investing.com South Africa

Jul 28, 2026

NeoGenomics pays $10 million to settle kickback allegations after self-disclosing below-market deals - Peoples Gazette Nigeria

Jul 28, 2026

Jul 27, 2026

NEO Balance Sheet - TradingKey

Jul 27, 2026

NEO|Neogenomics Inc|Price:13.890|Chg%:-0.350 - TradingKey

Jul 27, 2026

NEOUSD (NEOUSD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 27, 2026

NEO Income Statement - TradingKey

Jul 27, 2026

NEOUSD (NEOUSD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026

NeoGenomics (NEO) Q2 Earnings Report Preview: What To Look For - Yahoo! Finance Canada

Jul 27, 2026

NeoGenomics Laboratories to Pay $9.8 Million to Resolve FCA Allegations Relating to Below-Fair-Market-Value Consulting Services - ArentFox Schiff

Jul 27, 2026

Jul 26, 2026

Benchmark Co. Maintains NeoGenomics(NEO.US) With Buy Rating, Raises Target Price to $16 - Moomoo

Jul 24, 2026